T cell apoptosis signaling biomarker of PD-1 engagement in cancer patients

被引:0
|
作者
Zhao, Wei [1 ]
Dong, Haidong [1 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN USA
关键词
D O I
10.1158/1538-7445.AM2014-2552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2552
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling.
    Gao, Q.
    Bendersky, V.
    Kirk, A.
    Xu, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 362 - 362
  • [42] Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer
    Kim, Hye In
    Kim, Won Gu
    Kim, Mijin
    Ko, Nak Gyeong
    Jin, Mihyeon
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Choi, Yoon-La
    Jeon, Min Ji
    Kim, Tae Yong
    Kim, Won Bae
    Kim, Sang-We
    Lee, Dae Ho
    Jang, Se Jin
    Kim, Sun Wook
    Chung, Jae Hoon
    Kim, Tae Hyuk
    Lee, Se-Hoon
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [43] Enhanced recovery of PD-1 expression on the cell surface of PD-1 negative T cells in nivolumab-treated advanced melanoma patients
    Takahashi, R.
    Sato, Y.
    Kimishima, M.
    Ohyama, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S134 - S134
  • [44] Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma
    Kim, Kyu Seo
    Sekar, Rishi R.
    Patil, Dattatraya
    Dimarco, Michelle A.
    Kissick, Haydn T.
    Bilen, Mehmet A.
    Osunkoya, Adeboye O.
    Master, Viraj A.
    ONCOIMMUNOLOGY, 2018, 7 (04):
  • [45] Microsatellite Instability as a Biomarker for PD-1 Blockade
    Dudley, Jonathan C.
    Lin, Ming-Tseh
    Le, Dung T.
    Eshleman, James R.
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 813 - 820
  • [46] Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients
    Noda, Miwa
    Masuda, Takaaki
    Ito, Shuhei
    Tobo, Taro
    Kitagawa, Akihiro
    Hu, Qingjiang
    Shimizu, Dai
    Eguchi, Hidetoshi
    Etoh, Tsuyoshi
    Ohno, Shinji
    Inomata, Masafumi
    Mimori, Koshi
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 4035 - 4043
  • [47] Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients
    Sun, Jiangang
    Li, Xiaojing
    Wang, Qian
    Chen, Peng
    Zhao, Longfei
    Gao, Yongshun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
  • [49] Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients
    Miwa Noda
    Takaaki Masuda
    Shuhei Ito
    Taro Tobo
    Akihiro Kitagawa
    Qingjiang Hu
    Dai Shimizu
    Hidetoshi Eguchi
    Tsuyoshi Etoh
    Shinji Ohno
    Masafumi Inomata
    Koshi Mimori
    Annals of Surgical Oncology, 2020, 27 : 4035 - 4043
  • [50] MiR-BART9 is a prognostic biomarker associated with PD-1 expression in colon cancer patients
    Mariani, Marisa
    Pandya, Deep
    Andreoli, Mirko
    He, Shiquan
    Spennato, Manuela
    Ferlini, Cristiano
    CANCER RESEARCH, 2016, 76